Published in Alcohol Clin Exp Res on January 15, 2014
Genetic influences on adolescent behavior. Neurosci Biobehav Rev (2016) 0.88
Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use. Genes Brain Behav (2015) 0.84
Associations of rare nicotinic cholinergic receptor gene variants to nicotine and alcohol dependence. Am J Med Genet B Neuropsychiatr Genet (2016) 0.75
Evidence for Association Between Low Frequency Variants in CHRNA6/CHRNB3 and Antisocial Drug Dependence. Behav Genet (2016) 0.75
Recent Advances in Nicotinic Receptor Signaling in Alcohol Abuse and Alcoholism. Prog Mol Biol Transl Sci (2015) 0.75
Relative fluid novelty differentially alters the time course of limited-access ethanol and water intake in selectively bred high-alcohol-preferring mice. Alcohol Clin Exp Res (2015) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Actual causes of death in the United States. JAMA (1993) 28.34
Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet (1999) 23.67
Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet (2003) 21.52
Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry (2004) 8.45
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature (1998) 6.27
Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet (1998) 6.04
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science (2004) 5.94
Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychol Med (1997) 5.69
Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Arch Gen Psychiatry (2008) 3.57
Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet (2005) 2.80
Prospective associations of concerns about physique and the development of obesity, binge drinking, and drug use among adolescent boys and young adult men. JAMA Pediatr (2014) 2.78
Vital signs: binge drinking prevalence, frequency, and intensity among adults - United States, 2010. MMWR Morb Mortal Wkly Rep (2012) 2.74
Ethnic differences in alcohol sensitivity. Science (1972) 2.74
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci U S A (2007) 2.68
Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psychiatry (2008) 2.49
A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am J Hum Genet (2004) 2.47
Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry (2009) 2.25
The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol Psychiatry (2007) 2.19
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet (2008) 2.12
An overview of genetic influences in alcoholism. J Subst Abuse Treat (2009) 2.10
Epidemiologic analysis of alcohol and tobacco use. Alcohol Res Health (2000) 1.97
Early emerging nicotine-dependence symptoms: a signal of propensity for chronic smoking behavior in adolescents. J Pediatr (2010) 1.96
Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. Am J Med Genet B Neuropsychiatr Genet (2007) 1.82
Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction. Biochem Pharmacol (2007) 1.49
CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry (2007) 1.44
Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors. Eur J Pharmacol (2003) 1.44
Varenicline decreases alcohol consumption in heavy-drinking smokers. Psychopharmacology (Berl) (2012) 1.41
Smoking and the genetic contribution to alcohol-dependence risk. Alcohol Res Health (2000) 1.35
Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res (2000) 1.31
The relationship between genetic influences on alcohol dependence and on patterns of alcohol consumption. Alcohol Clin Exp Res (2010) 1.28
Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption. J Neurosci (2010) 1.28
A preliminary investigation of varenicline for heavy drinking smokers. Psychopharmacology (Berl) (2011) 1.27
The genetic components of alcohol and nicotine co-addiction: from genes to behavior. Curr Drug Abuse Rev (2008) 1.25
Mutational analysis of the nicotinic acetylcholine receptor alpha 4 subunit gene in attention deficit/hyperactivity disorder: evidence for association of an intronic polymorphism with attention problems. Mol Psychiatry (2003) 1.22
TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood. Biol Psychiatry (2010) 1.21
Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochem Pharmacol (2011) 1.17
Mechanistic studies of ethanol's interaction with the mesolimbic dopamine reward system. Pharmacopsychiatry (2009) 1.15
Association of nicotinic acetylcholine receptor subunit alpha 4 polymorphisms with nicotine dependence in 5500 Germans. Pharmacogenomics J (2009) 1.12
Voluntary ethanol intake increases extracellular acetylcholine levels in the ventral tegmental area in the rat. Alcohol Alcohol (2005) 1.11
SNPs in CHRNA6 and CHRNB3 are associated with alcohol consumption in a nationally representative sample. Genes Brain Behav (2009) 1.09
Time-varying effects of smoking quantity and nicotine dependence on adolescent smoking regularity. Drug Alcohol Depend (2012) 1.03
Interaction of the nicotinic cholinergic system with ethanol withdrawal. J Pharmacol Exp Ther (2003) 1.01
Shared genetic vulnerability in alcohol and cigarette use and dependence. Alcohol Clin Exp Res (2002) 0.99
Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene. PLoS One (2009) 0.93
Nicotinic acetylcholine receptors containing the α4 subunit modulate alcohol reward. Biol Psychiatry (2012) 0.91
Channel inhibition by alkanols occurs at a binding site on the nicotinic acetylcholine receptor. Mol Pharmacol (1995) 0.91
A cognitive phenotype for a polymorphism in the nicotinic receptor gene CHRNA4. Neurosci Biobehav Rev (2012) 0.90
Association of nAChR gene haplotypes with heavy alcohol use and body mass. Brain Res (2009) 0.89
Combined analysis of CHRNA5, CHRNA3 and CYP2A6 in relation to adolescent smoking behaviour. J Psychopharmacol (2011) 0.87
Effects of alcohols and volatile anesthetics on the activation of nicotinic acetylcholine receptor channels. Mol Pharmacol (1994) 0.87
Nominal association with CHRNA4 variants and nicotine dependence. Genes Brain Behav (2013) 0.86
Effect of neuronal nicotinic acetylcholine receptor genes (CHRN) on longitudinal cigarettes per day in adolescents and young adults. Nicotine Tob Res (2013) 0.82
Longitudinal associations between smoking cessation medications and alcohol consumption among smokers in the International Tobacco Control Four Country survey. Alcohol Clin Exp Res (2012) 0.81
Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15
Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature (2004) 24.40
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature (2012) 13.71
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron (2011) 10.61
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39
Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet (2007) 6.75
Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30
A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet (2008) 5.28
Combining information from multiple sources in the diagnosis of autism spectrum disorders. J Am Acad Child Adolesc Psychiatry (2006) 5.23
A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). J Consult Clin Psychol (2004) 4.24
Pattern of sequence variation across 213 environmental response genes. Genome Res (2004) 3.93
Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet (2010) 3.91
Autism as a paradigmatic complex genetic disorder. Annu Rev Genomics Hum Genet (2004) 3.65
High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett (2006) 3.64
A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42
Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet (2009) 3.42
A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet (2008) 3.25
A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch Gen Psychiatry (2011) 2.99
Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol (2012) 2.77
Common genetic variants, acting additively, are a major source of risk for autism. Mol Autism (2012) 2.67
Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol Psychiatry (2008) 2.60
Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46
Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron (2013) 2.45
The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med (2011) 2.43
Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neurosci Lett (2007) 2.38
Affective instability: measuring a core feature of borderline personality disorder with ecological momentary assessment. J Abnorm Psychol (2008) 2.38
Life before and after quitting smoking: an electronic diary study. J Abnorm Psychol (2006) 2.30
Between a ROC and a hard place: decision making and making decisions about using the SCQ. J Child Psychol Psychiatry (2007) 2.26
Analysis of binary outcomes with missing data: missing = smoking, last observation carried forward, and a little multiple imputation. Addiction (2007) 2.17
Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity. Cancer Res (2004) 2.10
Rapid direct sequence analysis of the dystrophin gene. Am J Hum Genet (2003) 2.07
Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Am J Psychiatry (2012) 2.02
Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry (2006) 2.02
Profiling patterned transcripts in Drosophila embryos. Genome Res (2002) 1.96
Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat (2009) 1.88
Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives. J Abnorm Psychol (2008) 1.86
A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. Proc Natl Acad Sci U S A (2012) 1.85
Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob Res (2009) 1.84
Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy. Circ Cardiovasc Genet (2009) 1.80
A strong signature of balancing selection in the 5' cis-regulatory region of CCR5. Proc Natl Acad Sci U S A (2002) 1.78
An application of a mixed-effects location scale model for analysis of Ecological Momentary Assessment (EMA) data. Biometrics (2007) 1.77
Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. Sci Transl Med (2010) 1.75
Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol (2003) 1.75
Using the autism diagnostic interview--revised to increase phenotypic homogeneity in genetic studies of autism. Biol Psychiatry (2007) 1.75
A Practical Guide to Calculating Cohen's f(2), a Measure of Local Effect Size, from PROC MIXED. Front Psychol (2012) 1.70
A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. Nicotine Tob Res (2008) 1.70
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Modeling mood variation associated with smoking: an application of a heterogeneous mixed-effects model for analysis of ecological momentary assessment (EMA) data. Addiction (2009) 1.66
LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann Neurol (2013) 1.63
A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res (2005) 1.62
Independent evolution of bitter-taste sensitivity in humans and chimpanzees. Nature (2006) 1.59
Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest (2008) 1.57
Analysis of rare, exonic variation amongst subjects with autism spectrum disorders and population controls. PLoS Genet (2013) 1.53
Psychological mediators of bupropion sustained-release treatment for smoking cessation. Addiction (2008) 1.53
Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood (2007) 1.52
MECP2 structural and 3'-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism. Am J Med Genet B Neuropsychiatr Genet (2004) 1.51
5-HTTLPR Genotype-Specific Phenotype in Children and Adolescents With Autism. Am J Psychiatry (2006) 1.49
Fine-scaled human genetic structure revealed by SNP microarrays. Genome Res (2009) 1.48
Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol (2004) 1.48
Toward a more uniform sampling of human genetic diversity: a survey of worldwide populations by high-density genotyping. Genomics (2010) 1.47
New complexities in the genetics of stuttering: significant sex-specific linkage signals. Am J Hum Genet (2006) 1.46
Commentary from the DSM-5 Workgroup on Neurodevelopmental Disorders. J Am Acad Child Adolesc Psychiatry (2012) 1.45
A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet (2011) 1.43
Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood (2005) 1.42
Genetic studies of stuttering in a founder population. J Fluency Disord (2006) 1.39
Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. Clin Cancer Res (2003) 1.37
Development and initial validation of the Hangover Symptoms Scale: prevalence and correlates of Hangover Symptoms in college students. Alcohol Clin Exp Res (2003) 1.36
Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet (2002) 1.35
Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry (2004) 1.34
Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology (2005) 1.34
Toward a dimensional and psychometrically-informed approach to conceptualizing psychopathology. Behav Res Ther (2002) 1.34
EGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression. Blood (2007) 1.33
DMD Trp3X nonsense mutation associated with a founder effect in North American families with mild Becker muscular dystrophy. Neuromuscul Disord (2009) 1.31
Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism. Am J Med Genet (2002) 1.31
Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology (2006) 1.30
Association and mutation analyses of 16p11.2 autism candidate genes. PLoS One (2009) 1.27
Sex-specific genetic architecture of whole blood serotonin levels. Am J Hum Genet (2004) 1.26
A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr (2012) 1.26
Adolescents' smoking expectancies: psychometric properties and prediction of behavior change. Nicotine Tob Res (2005) 1.25
Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul Disord (2010) 1.24
Use of array CGH to detect exonic copy number variants throughout the genome in autism families detects a novel deletion in TMLHE. Hum Mol Genet (2011) 1.22
DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy. Ann Neurol (2008) 1.22
Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines. Clin Cancer Res (2007) 1.20
The natural course of nicotine dependence symptoms among adolescent smokers. Nicotine Tob Res (2012) 1.19
Genome degeneration and adaptation in a nascent stage of symbiosis. Genome Biol Evol (2014) 1.18
A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. J Child Adolesc Psychopharmacol (2005) 1.16
Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders. J Clin Exp Neuropsychol (2012) 1.15
Gene expression profiling reveals unique pathways associated with differential severity of lyme arthritis. J Immunol (2006) 1.15
Allele-specific expression analysis by RNA-FISH demonstrates preferential maternal expression of UBE3A and imprint maintenance within 15q11- q13 duplications. Hum Mol Genet (2002) 1.15
Recruitment and retention of adolescents in a smoking trajectory study: who participates and lessons learned. Subst Use Misuse (2006) 1.15
Genome-wide association study identifies ITGB3 as a QTL for whole blood serotonin. Eur J Hum Genet (2004) 1.15